Tag: Prescription Drugs
Bamlanivimab + Etesevimab Reduces SARS-CoV-2 Viral Load
No significant reduction seen in viral load at day 11 with bamlanivimab monotherapy in mild-to-moderate COVID-19
FDA Approves First Monthly Injectable Regimen for HIV
Trials show virologic suppression in comparable numbers of patients receiving monthly injection with Cabenuva, daily current antiretroviral regimen
Antibody Drug May Protect Nursing Home Residents, Staff From COVID-19
Preliminary results of the study conducted by drug maker Eli Lilly have not been peer-reviewed or published
Tocilizumab Does Not Improve Outcomes in Severe COVID-19
Tocilizumab plus standard care no better for improving clinical outcomes at 15 days and may increase mortality
Denosumab Studied for Prosthesis-Related Osteolysis
Fewer osteoclasts seen at osteolysis membrane-bone interface with denosumab versus placebo in patients undergoing revision hip arthroplasty
Continuing Blood Pressure Meds Safe for Those With COVID-19
No difference in outcomes seen among hospitalized COVID-19 patients continuing, discontinuing renin-angiotensin system inhibitors
USPSTF Affirms Evidence-Based Methods for Smoking Cessation
Behavioral and pharmacotherapy interventions, alone or in combination, recommended; evidence insufficient for e-cigarettes
Bupropion-Naltrexone Bests Placebo in Methamphetamine Use Disorder
Response was low but higher with naltrexone-bupropion than placebo during 12-week, two-stage trial
Stopping RAS Inhibitors May Worsen Outcomes in CKD
Stopping therapy tied to lower risk for dialysis, but higher risk for cardiovascular events and death
Inhaled Treprostinil Beneficial in Pulmonary Hypertension
Exercise capacity improved, clinical worsening reduced for patients with pulmonary HTN due to interstitial lung disease
